“Daily Practice Use of Bortezomib in Relapsed Refractory Multiple Myeloma: Safety Efficacy Results of a Compassionate Use Program in Switzerland”. 2007. Swiss Medical Weekly 137 (2122): 317-22. https://doi.org/10.4414/smw.2007.11716.